Covis, CDER Lay Out Arguments Ahead Of Makena’s Accelerated Approval Withdrawal Hearing

 
• By Sue Sutter
Narrow path
Covis' preferred path for Makena is to narrow the current indication while conducting a new randomized, controlled trial. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards